Effectiveness of Cortisone Injection and Splinting for Trigger Finger

• Status: Recruiting
• Trial end date: 2022-09-01
• Target enrollment: 0
• Participant gender: All

Summary

Trigger finger has a prevalence rate of up to 3%. There are many approaches available to manage this condition. While corticosteroid injection is widely accepted as the most common first-line treatment, its superiority over splint treatment has not been established. This study aims to test the effectiveness of cortisone injections, splint and cortisone+splint to resolve symptoms.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Lawson Health Research Institute; Ruby Grewal
• Treatments: Betamethasone; Cortisone; Cortisone acetate

Criteria

Inclusion Criteria:

1. Skeletally mature adults

2. Symptom duration of at least 3 months

3. Diagnosis of trigger finger: based on history of triggering and physical examination (pain over the flexor tendon, tenderness or nodule over the A1 pulley, stiffness, and reproducible locking or triggering).

4. Green's Grade 1-3 (Green's Classification to Grade the Severity of Trigger Finger)

Exclusion Criteria:

1. Congenital trigger thumb

2. Green's Grade 4 (fixed flexion contracture)

3. Previous treatment for trigger finger (injection or surgery)

4. Allergy to cortisone

5. Multiple digits (>2 digits)